論文一覧
横スクロールして、ご覧ください。
| Title | Authors | Journal | Year | Vol | Pages |
|---|---|---|---|---|---|
| Contribution of non-coding RNAs to anticancer effects of dietary polyphenols: chlorogenic acid, curcumin, epigallocatechin-3-gallate, genistein, quercetin and resveratrol. | S. Hayakawa, T. Ohishi, Y. Oishi, M. Isemura, and N. Miyoshi | Antioxidants | 2022 | 11 | 2352. https://doi.org/10.3390/antiox11122352 |
| A defucosylated anti-EpCAM monoclonal antibody (EpMab-37-mG2a-f) exerts antitumor activity in xenograft model. | T. Asano, T. Tanaka, H. Suzuki, G. Li, T. Ohishi, M. Kawada, T. Yoshikawa, M. K. Kaneko, and Y. Kato | Antibodies | 2022 | 11 | 74. https://doi.org/10.3390/antib11040074 |
| Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody (H77Bf) exerts antitumor activities in mouse xenograft models of canine osteosarcoma. | R. Nanamiya, T. Ohishi, H. Suzuki, T. Mizuno, T. Yoshikawa, T. Asano, T. Tanaka, M. K. Kaneko, and Y. Kato | Monoclon. Antib. Immunodiagn. Immunother. | 2022 | doi:10.1089/mab.2022.0022 | |
| Antitumor activity of an anti-EGFR/HER2 bispecific antibody in a mouse xenograft model of canine osteosarcoma. | N. Tateyama, H. Suzuki, T. Ohishi, T. Asano, T. Tanaka, T. Mizuno, T. Yoshikawa, M. Kawada, M. K. Kaneko, and Y. Kato | Pharmaceutics | 2022 | 14 | 2494, https://doi.org/10.3390/pharmaceutics14112494 |
| Antitumor activities in mouse xenograft models of canine fibroblastic tumor by defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody (H77Bf). | H. Suzuki, T. Asano, T. Ohishi, T. Yoshikawa, H. Suzuki, T. Mizuno, T. Tanaka, M. Kawada, M. K. Kaneko, and Y. Kato | Monoclon. Antib. Immunodiagn. Immunother. | 2022 | doi: 10.1089/mab.2022.0023 | |
| Antisense gapmers with LNA-wings and (S)-5′-C-aminopropyl-2-arabinofluoro-nucleosides could efficiently suppress the expression of KNTC2. |
Y. Zhou, S. Sakamoto and Y. Ueno | Molecules | 2022 | 27 | 7384. doi: 10.3390/molecules27217384 |
| A missing link in multisubstituted pyrrolidines: remote stereocontrol forged by rhodium-alkyl nitrene. | X. Tang, R. K. Tak, H. Noda, and M. Shibasaki | Angew. Chem. Int. Ed. | 2022 | 61 | doi: 10.1002/anie.202212421. |
| Targeting the ATG5-ATG16L1 protein-protein interaction with a hydrocarbon-stapled peptide derived from ATG16L1 for autophagy inhibition. | J. Cui, Y. Ogasawara, I. Kurata, K. Matoba, Y. Fujioka, N. N. Noda, M. Shibasaki, and T. Watanabe | J. Am. Chem. Soc. | 2022 | 144 | doi: 10.1021/jacs.2c07648 |
| Anti‑lung cancer properties of cyanobacterial bioactive compounds. | M. S. Baig, S. Rajpoot, T. Ohishi, R. Savai, S. Seidel, N. A. Kamennaya, E. E. Bezsonov, A. N. Orekhov, P. Mahajan, K. Solanki, and U. Saqib | Archives of Microbiology | 2022 | 204 | 603, https://doi.org/10.1007/s00203-022-03194-0 |
| Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer. | Y. Kubota, Y. Fujioka, A. Patil, Y. Takagi, D. Matsubara, M. Iijima, I. Momose, R. Naka, K. Nakai, N. N. Noda, and M. Takekawa | Nat. Commun. | 2022 | 13 | 4063. doi: 10.1038/s41467-022-31690-w. |
| Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations. | K. Solanki, S. Rajpoot, A. Kumar, K. Y J Zhang, T. Ohishi, N. Hirani, K. Wadhonkar, P. Patidar, Q. Pan, and M. S Baig | Future Virol. | 2022 | Jul; 10.2217/fvl-2022-0003. doi: 10.2217/fvl-2022-0003. | |
| Short peptides derived from hGAPDH exhibit anti-cancer activity. | J. Yoshida, K. Takayama, and M. Kawada | Bioorganic & Medicinal Chemistry | 2022 | 71 | 116953. doi.org/10.1016/j.bmc.2022.116953 |
| Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors. | H. Suzuki, T. Ohishi, T. Asano, T. Tanaka, M. Saito, T. Mizuno, T. Yoshikawa, M. Kawada, M. K. Kaneko, and Y. Kato | Oncol. Rep. | 2022 | 48 | 154. doi: 10.3892/or.2022.8366 |
| Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2. | T. Ohishi, T. Hishiki, M. S. Baig, S. Rajpoot, U. Saquib, T. Takasaki, and Y. Hara | PLoS One | 2022 | 17 | e0271112. doi: 10.1371/journal.pone.0271112 |
| Anti-cancer effects of dietary polyphenols via ROS-mediated pathway with their modulation of microRNAs. | Y. Yoshioka, T. Ohishi, Y. Nakamura, R. Fukutomi and N. Miyoshi | Molecules | 2022 | 27 | 3816. doi.org/10.3390/molecules27123816 |
| Defucosylated anti-EGFR monoclonal antibody exerted antitumor activities in mouse xenograft models of canine mammary gland tumor. |
T. Tanaka, T, Ohishi, M. Saito, H. Suzuki, M. K. Kaneko, M. Kawada, and Y. Kato | Monoclonal Antibodies in Immunodiagnosis and Immunuotherapy |
2022 | 41 | 142-149. doi: 10. 1089/mab. 2022. 0009 |
| A novel E198K substitution in the PA gene of influenza A virus with reduced susceptibility to baloxavir acid. | N. Takizawa and F. Momose |
Arch. Virol. |
2022 | 167 | 1565-1570 (doi: 10.1007/s00705-022-05456-0) |
| Diastereoselective direct catalytic asymmetric Mannich-type reactions of alkylnitriles with a Ni(II)-carbene complex. | S. Adachi, A. Saito, and M. Shibasaki | Org. Lett. | 2022 | 24 | 3901-3906. doi.org/10.1021/acs.orglett.2c01624 |
| A defucosylated mouse anti-CD10 monoclonal antibody (31-mG2a-f) exerts antitumor activity in a mouse xenograft model of renal cell cancers. | H. Kawabata, T. Ohishi, H. Suzuki, T. Asano, M. Kawada, H. Suzuki, M. K. Kaneko and Y. Kato | Monoclon Antib Immunodiagn Immunother. | 2022 | doi. org/10. 1089/mab. 2021. 0049. PMID: 35483055 | |
| Concise and stereodivergent approach to chromanone lactones through copper-catalyzed asymmetric vinylogous addition of siloxyfurans to 2-ester-substituted chromones. | J. Cui, R. Oriez, H. Noda, T. Watanabe and M. Shibasaki | Angew. Chem. Int. Ed. | 2022 | 61 | e202203128 (doi. org/10. 1002/anie. 202203128) |
| A defucosylated mouse anti-CD10 monoclonal antibody (31-mG2a-f) exerts antitumor activity in a mouse xenograft model of CD10-overexpressed tumors. | H. Kawabata, H. Suzuki, T. Ohishi, M. kawada, M. K. Kaneko and Y. Kato | Monoclon Antib Immunodiagn Immunother. | 2022 | 41 | 59-66. doi: 10.1089/mab. 2021. 0048. PMID: 35471051 |
| Antitumor activities in mouse xenograft models of canine mammary gland tumor by defucosylated mouse-dog chimeric anti-EGFR antibody (E134Bf). | G. Li, H. Suzuki, J. Takei, T. Asano, M. Sano, T. Tanaka, H. Harada, T. Mizuno, T. Ohishi, M. Kawada, M. K. Kaneko and Y. Kato | Monoclon Antib Immunodiagn Immunother. | 2022 | 41 | 53-58. doi: 10.1089/mab. 2021. 0040. PMID: 35471048 |
| Synthesis, gene silencing activity, thermal stability, and serum stability of siRNA containing four (S)-5’-C-aminopropyl-2’-O-methylnucleosides (A, adenosine; U, uridine; G, guanosine; and C, cytidine). | R. Kajino, S. Sakamoto and Y. Ueno | RSC Advances | 2022 | 12 | 11454. doi.org/10.1039/D2RA00705C |
| Antitumor activities in mouse xenograft models of canine fibroblastic tumor by defucosylated anti-EGFR monoclonal antibody. | N. Goto, H. Suzuki, T. Ohishi, A. Harakawa, G. Li, M. Saito, J. Takei, T. Tanaka, T. Asano, M. Sano, M. Kawada, M. Kaneko, and Y. Kato | Monoclonal Antibodies in Immunodiagnosis and Immunotherapy | 2022 | 42 | doi: 10.1089/mab.2021.0059 |
| Synthesis and antiviral activity of formycin derivatives with anti-influenza virus activity. | H. Takada, N. Takizawa, S. Shibasaki, H. Asaba, M. Igarashi, M. Shibasaki and Y. Takahashi | Bioorganic & Medicinal Chemistry | 2022 | 57 | https://doi.org/10.1016/j.bmc.2022.116613 |
| Rediscovery of 4-trehalosamine as a biologically stable, mass-producible, and chemically modifiable trehalose analog. | S. Wada, H. Arimura, M. Nagayoshi, R. Sawa, Y. Kubota, K. Matoba, C. Hayashi, Y. Shibuya, M. Hatano, Y. Takehana, S. Ohba, Y. Kobayashi, T. Watanabe, M. Shibasaki, and M. Igarashi | Advanced Biology | 2022 | 6 | https://doi.org/10.1002/adbi. 202101309 |
| Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curry. | T. Ohishi, S. Hayakawa and N. Miyoshi | Critical Reviews in Food Science and Nutrition | 2022 | 62 | https://doi.org/10.1080/10408398. 2022. 2038540 |
| TrMab-6 exerts antitumor activity in mouse xenograft models of breast cancers. | T. Tanaka, T. Ohishi, M. Saito, M. Kawada, M. K. Kaneko and Y. Kato | Monoclon Antib Immunodiagn Immunother. | 2022 | 41 | 32-38. doi:10.1089/mab.2021.0056. PMID: 35225665 |
| Defucosylated anti-EGFR monoclonal antibody (134-mG2a-f) exerts antitumor activities in mouse xenograft models of canine osteosarcoma. | R. Nanamiya, J. Takei, T. Ohishi, T. Asano, T. Tanaka, M. Sano, T. Nakamura, M. Yanaka, S. Handa, Y. Komatsu, H. Hosono, N. Tateyama, Y. Harigae, M. Saito, H. Suzuki, M. Kawada, M. K. Kaneko and Y. Kato | Monoclon Antib Immunodiagn Immunother. | 2022 | 41 | 1-7. doi: 10.1089/mab.2021.0036. PMID: 35225663 |
| Anti-influenza virus activity of methylthio-formycin distinct from that of T-705. |
N. Takizawa, H. Takada, M. Umekita, M. Igarashi and Y. Takahashi | Front Microbiol. | 2022 | 13 | 802671. doi:10.3389/fmicb.2022.802671 |
| Update and nomenclature proposal for mammalian lysophospholipid acyltransferases which create membrane phospholipid diversity. | W. J. Valentine, K. Yanagida, H. Kawana, N. Kono, N. N. Noda, J. Aoki and H. Shindou. | J. Biol. Chem. | 2022 | 298 | 101470. doi: 10.1016/j.jbc.2021.101470 |
| Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice. | A. Leesombun, CI. Nihei, D. Kondoh and Y. Nishikawa | Parasitol. Res. | 2022 | 121 | 413-422. doi: 10.1007/s00436-021-07363-w. |
| Isolation of new derivatives of the 20-membered macrodiolide bispolide from Kitasatospora sp. MG372-hF19. | Y. Kohda, S. Sakamoto, M. Umekita,, T. Kimura, Y. Kubota, R. Arisaka, Y. Shibuya, H. Muramatsu, R. Sawa, S. Dan, M. Kawada and M. Igarashi | J. Antibiot. | 2022 | 75 | 77-85. doi.org/10.1038/s41429-021-00492-5 |